高危住院患者早期腹腔穿刺:是时候建立新的质量指标了
该研究基于2009至2013年纽约、佛罗里达和华盛顿州住院数据库的75,462例肝硬化腹水并行腹腔穿刺的成人出院记录,发现高危患者(合并肝性脑病或急性肾损伤)早期腹腔穿刺率更低(52.8% vs 60.5%),且早期腹腔穿刺与降低住院全因死亡、SBP相关死亡及30天再入院相关。作者提出早期腹腔穿刺应作为新的质量指标。
要点
- 高危肝硬化腹水患者早期腹腔穿刺率显著低于非高危患者。
- 早期腹腔穿刺与降低住院全因死亡、SBP相关死亡和30天再入院相关。
- 建议将早期腹腔穿刺作为新的质量指标以改善预后。
核心结论
- 早期腹腔穿刺与降低住院全因死亡率、SBP相关死亡率和30天再入院率相关,应作为新的质量指标。
研究设计与样本
- 回顾性队列研究,纳入2009至2013年纽约、佛罗里达和华盛顿州住院数据库中75,462例因腹水行腹腔穿刺的成人肝硬化出院记录。
- 高危患者定义为入院时合并肝性脑病或急性肾损伤。
- 主要结局为早期腹腔穿刺(住院第1天内),次要结局为住院死亡率、SBP相关死亡率和30天再入院。
主要发现
- 43,492例(57.6%)患者接受了早期腹腔穿刺。
- 高危患者(27,496例)早期腹腔穿刺率更低:52.8% vs 60.5%,P < 0.001。
- 多变量分析显示高危患者接受早期腹腔穿刺的比值比降低(OR 0.74,95% CI 0.71-0.78,P < 0.001)。
- 早期腹腔穿刺与降低住院全因死亡率相关(OR 0.68,95% CI 0.63-0.73,P < 0.001)。
- 早期腹腔穿刺与降低SBP相关死亡率(OR 0.84,95% CI 0.73-0.94,P = 0.01)和30天再入院(OR 0.87,95% CI 0.82-0.92,P < 0.001)相关。
临床怎么用
- 对肝硬化腹水住院患者,尤其合并肝性脑病或急性肾损伤的高危患者,应尽早(住院第1天内)完成腹腔穿刺。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Symptomatic ascites is the most common indication for hospitalization in patients with cirrhosis. Although guidelines recommend paracentesis for all inpatients with ascites, the timing of paracentesis is likely to be crucial. Performance of an early paracentesis and its relationship to outcomes are unknown, particularly among patients at high risk of spontaneous bacterial peritonitis (SBP). METHODS: We included 75,462 discharges of adult patients with cirrhosis presenting with ascites who underwent paracentesis from the State Inpatient Databases of New York, Florida, and Washington from 2009 to 2013. High-risk patients were identified as having concomitant hepatic encephalopathy or acute kidney injury present on admission. The primary outcome was performance of early paracentesis (within 1 hospital day) with secondary outcomes being inpatient mortality, SBP-related mortality, and 30-day readmission. Multivariable logistic regression models included a priori covariates known to impact outcomes. RESULTS: There were 43,492 (57.6%) patients who underwent early paracentesis. High-risk patients (27,496) had lower rates of early paracentesis (52.8% vs 60.5%, P < 0.001). On multivariable analysis, high-risk patients had significantly decreased odds of undergoing early paracentesis (odds ratio [OR] 0.74, 95% confidence interval [CI] 0.71-0.78, P < 0.001). Early paracentesis was associated with a reduced inpatient all-cause mortality (OR 0.68, 95% CI 0.63-0.73, P < 0.001), SBP-related mortality (OR 0.84, 95% CI 0.73-0.94, P = 0.01), and 30-day readmission (OR 0.87, 95% CI 0.82-0.92, P < 0.001). DISCUSSION: Early paracentesis is associated with reduced inpatient mortality, SBP-related mortality, and 30-day readmission. Given its impact on outcomes, early paracentesis should be a new quality metric. Further education and interventions are needed to improve both adherence and outcomes.
引用
- Rosenblatt R, Tafesh Z, Shen N, et al. Early Paracentesis in High-Risk Hospitalized Patients: Time for a New Quality Indicator. Am J Gastroenterol. 2019. PMID: 31688022. doi:10.14309/ajg.0000000000000443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。